Processa Pharmaceuticals, Inc. (PCSA) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
PCSA Historical Performance
Short-Term Returns
PCSA Stock Price Trajectory (2014–2026)
As of May 8, 2026, Processa Pharmaceuticals, Inc. (PCSA) trades at $2.87, representing a +1014.1% return over the past year. The stock has delivered a -97.9% total return over five years (-53.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $717.50 on March 14, 2018. From this peak, PCSA has corrected -99.6%, currently trading 39% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ATHA (+81.6% 1Y), NUVB (+136.3% 1Y), and CRVS (+355.9% 1Y), PCSA has outperformed the peer group average. Compare PCSA vs ATHA →
PCSA Historical Price Data (2025–2026)
Showing 30 of 3,062 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 2.78 | 2.94 | 2.78 | 2.87 | 25K | +4.36% |
| 2026-05-06 | 2.66 | 2.77 | 2.61 | 2.75 | 18K | +3.38% |
| 2026-05-05 | 2.68 | 2.72 | 2.62 | 2.66 | 18K | -0.75% |
| 2026-05-04 | 2.69 | 2.69 | 2.64 | 2.68 | 24K | +5.10% |
| 2026-05-01 | 2.67 | 2.71 | 2.50 | 2.55 | 35K | -5.56% |
| 2026-04-30 | 2.74 | 2.89 | 2.61 | 2.70 | 13K | +1.89% |
| 2026-04-29 | 2.74 | 2.94 | 2.57 | 2.65 | 72K | -6.85% |
| 2026-04-28 | 2.97 | 2.97 | 2.85 | 2.85 | 23K | -4.69% |
| 2026-04-27 | 3.01 | 3.02 | 2.96 | 2.98 | 12K | +0.17% |
| 2026-04-24 | 3.00 | 3.00 | 2.89 | 2.98 | 21K | -0.33% |
| 2026-04-23 | 3.11 | 3.11 | 2.98 | 2.99 | 20K | -2.61% |
| 2026-04-22 | 2.82 | 3.27 | 2.82 | 3.07 | 190K | +11.03% |
| 2026-04-21 | 2.79 | 2.93 | 2.71 | 2.77 | 60K | +2.03% |
| 2026-04-20 | 3.38 | 3.38 | 2.71 | 2.71 | 149K | -12.58% |
| 2026-04-17 | 3.30 | 3.45 | 3.08 | 3.10 | 90K | -2.52% |
| 2026-04-16 | 3.05 | 3.28 | 3.00 | 3.18 | 135K | +7.43% |
| 2026-04-15 | 2.80 | 2.99 | 2.76 | 2.96 | 67K | +3.14% |
| 2026-04-14 | 2.79 | 2.88 | 2.73 | 2.87 | 17K | 0.00% |
| 2026-04-13 | 2.72 | 2.91 | 2.72 | 2.87 | 36K | +3.61% |
| 2026-04-10 | 2.98 | 2.98 | 2.75 | 2.77 | 35K | -6.73% |
| 2026-04-09 | 3.02 | 3.13 | 2.96 | 2.97 | 48K | -1.66% |
| 2026-04-08 | 2.80 | 3.02 | 2.73 | 3.02 | 51K | +5.23% |
| 2026-04-07 | 2.85 | 2.94 | 2.59 | 2.87 | 67K | +2.50% |
| 2026-04-06 | 2.85 | 2.99 | 2.67 | 2.80 | 264K | +1.08% |
| 2026-04-02 | 2.87 | 3.22 | 2.55 | 2.77 | 193K | +6.42% |
| 2026-04-01 | 2.54 | 2.74 | 2.51 | 2.60 | 14K | +3.09% |
| 2026-03-31 | 2.70 | 2.72 | 2.45 | 2.52 | 31K | -7.17% |
| 2026-03-30 | 2.48 | 2.76 | 2.33 | 2.72 | 101K | +11.93% |
| 2026-03-27 | 2.30 | 2.69 | 2.30 | 2.43 | 52K | +8.48% |
| 2026-03-26 | 2.29 | 2.43 | 2.24 | 2.24 | 19K | -5.49% |
See PCSA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PCSA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PCSA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPCSA — Frequently Asked Questions
Quick answers to the most common questions about buying PCSA stock.
How has PCSA stock performed recently?
PCSA returned +1014.1% over the past year, beating its 5-year annualized CAGR of -53.9%. The stock trades below its 200-day moving average, confirming the uptrend.
What is PCSA's all-time high price?
Processa Pharmaceuticals, Inc. reached $717.50 on 2018-03-14. The 52-week high is $8.88. Current 1-year return of +1014.1% places the stock closer to historical peaks.
Where can I download PCSA historical price data?
This page provides PCSA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.